Loading asset research
First Tracks Biotherapeutics Inc. Ordinary Shares
TRAXNasdaq · USD · StocksQuote as of · Exchange session not verified$39.16
+0.41%
Today
TRAX
Loading 1D prices…
Market cap
$1.4B
Volume
554.8K
52w high
$49.9152w low
$14.72Company profile
First Tracks Biotherapeutics Inc. Ordinary Shares
First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
104
Fiscal year end
1231
CIK
2091349
Session & valuation
Open$39.91
Previous close$39.00
Day high$41.90
Day low$39.13
30-day avg. volume581.8K
Outstanding shares35.7M
Diluted EPS-$3.05
Latest annual period
P/E (trailing)-12.82
P/E (forward)-10.59
Price / book8.22
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PAHCPhibro Animal Health Corporation Class A Common Stock | $1.4B | $1.5B | +6.57% | $2.43 | -2.49% | Hold |
| AVBPArriVent BioPharma Inc. Common Stock | $1.4B | $0.00 | — | -$4.32 | +2.60% | Buy |
| DMRADamora Therapeutics Inc. Ordinary Shares | $1.4B | $0.00 | — | $3.98 | -7.30% | Buy |
| RAREUltragenyx Pharmaceutical Inc. Common Stock | $1.4B | $673M | -85.44% | -$5.83 | +12.58% | Hold |
| AAPGAscentage Pharma Group International American Depository Shares | $1.4B | — | — | -$13.96 | -0.19% | Buy |